Pharmaceuticals, Biotechnology and Life Sciences
SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics today announced the appointment of Andy Meyer as Chief Business Officer. Mr. Meyer has more than 10 years of experience in biotechnology as an investment banker at Evercore and BofA Securities, Inc., where…
SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics today announced the appointment of Andy Meyer as Chief Business Officer. Mr. Meyer has more than 10 years of experience in biotechnology as an investment banker at Evercore and BofA Securities, Inc., where…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Repertoire Immune Medicines, a clinical-stage biotech company creating a new category of immune therapies for cancer, autoimmunity and infectious disease, today announced that John Cox, Chief Executive Officer, will p…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Repertoire Immune Medicines, a clinical-stage biotech company creating a new category of immune therapies for cancer, autoimmunity and infectious disease, today announced that John Cox, Chief Executive Officer, will p…
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Repertoire Immune Medicines, a clinical-stage biotech company creating a new category of immune therapies for cancer, autoimmunity and infectious disease, today announced that John Cox, Chief Executive Officer, will p…
Initial preclinical data shows MV-014-212 induced a SARS-CoV-2-specific mucosal IgA response, generated serum neutralizing antibodies, and provided efficacy against challenge
REDWOOD CITY, Calif.–(BUSINESS WIRE)–#COVID19–Meissa Vaccines (“Meissa”),…
SAN DIEGO–(BUSINESS WIRE)–Janux Therapeutics today announced the appointment of Andy Meyer as Chief Business Officer. Mr. Meyer has more than 10 years of experience in biotechnology as an investment banker at Evercore and BofA Securities, Inc., where…
OXNARD, Calif.–(BUSINESS WIRE)–CURE Pharmaceutical Holding Corp. (“CURE” or the “Company”) (OTC: CURR), a vertically integrated drug delivery and product development company, announced today that it has launched a new initiative for the clinical deve…
Preliminary Data from Single-Ascending Dose Cohorts Expected Later this Year
CAMBRIDGE, Mass. & LAUSANNE, Switzerland–(BUSINESS WIRE)–Anokion SA, a Swiss biotechnology company focused on treating autoimmune disease by restoring normal immune toleran…
RENAsym SAB to Provide Insights and Guidance for Development of Kidney Injury Software
LANCASTER, Calif.–(BUSINESS WIRE)–Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical saf…